Phibro Animal Health (PAHC) Tops Q3 EPS by 5c, updates guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.76, $0.05 better than the analyst estimate of $0.71. Revenue for the quarter came in at $383.5 million versus the consensus estimate of $365.2 million.

GUIDANCE:

Phibro Animal Health sees FY2026 revenue of $1.46-1.5 billion, versus the consensus of $1.488 billion.
Adjusted EBITDA of $247 million to $255 million

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Uber sells part of its Aurora stake in block trade - Bloomberg
• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• Home Depot beats estimates, reaffirms fiscal 2026 guidance